Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Should schizophrenia be treated as a neurocognitive disorder?

Green MF, Nuechterlein KH.

Schizophr Bull. 1999;25(2):309-19. Review.

PMID:
10416733
2.

The effects of neurocognitive remediation on executive processing in patients with schizophrenia.

Wykes T, Reeder C, Corner J, Williams C, Everitt B.

Schizophr Bull. 1999;25(2):291-307.

PMID:
10416732
3.

Studying the effectiveness of neurocognitive remediation in schizophrenia.

Jaeger J.

Schizophr Bull. 1999;25(2):193-6. No abstract available.

PMID:
10416725
4.

Interventions for neurocognitive deficits: editor's introduction.

Green MF.

Schizophr Bull. 1999;25(2):197-200. No abstract available.

PMID:
10416726
5.

[Learning potential and cognitive remediation in schizophrenia].

Raffard S, Gely-Nargeot MC, Capdevielle D, Bayard S, Boulenger JP.

Encephale. 2009 Sep;35(4):353-60. doi: 10.1016/j.encep.2008.06.014. Epub 2009 Jan 8. Review. French.

PMID:
19748372
6.

Treatment of cognitive dysfunction in psychiatric disorders.

Medalia A, Lim R.

J Psychiatr Pract. 2004 Jan;10(1):17-25.

PMID:
15334984
7.

Cognitive deficits and cognitive training in schizophrenic patients: a review.

Rund BR, Borg NE.

Acta Psychiatr Scand. 1999 Aug;100(2):85-95. Review.

PMID:
10480194
8.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
9.

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Keefe RS, Silva SG, Perkins DO, Lieberman JA.

Schizophr Bull. 1999;25(2):201-22.

PMID:
10416727
10.

Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies.

Bellack AS, Gold JM, Buchanan RW.

Schizophr Bull. 1999;25(2):257-74. Review.

PMID:
10416730
11.

Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment.

Velligan DI, Miller AL.

J Clin Psychiatry. 1999;60 Suppl 23:25-8. Review.

PMID:
10625197
12.

[Neurocognition, psychosocial outcome and vocational integration].

Krüger T, Schönhoff M, Dettling M.

Psychiatr Prax. 2004 Nov;31 Suppl 2:S224-9. Review. German.

PMID:
15586314
13.

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

Green MF, Kern RS, Braff DL, Mintz J.

Schizophr Bull. 2000;26(1):119-36. Review.

PMID:
10755673
14.

The staging model in schizophrenia, and its clinical implications.

Agius M, Goh C, Ulhaq S, McGorry P.

Psychiatr Danub. 2010 Jun;22(2):211-20. Review.

PMID:
20562749
15.

Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.

Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M.

Schizophr Bull. 2003;29(1):45-55.

PMID:
12908660
16.
17.

Neurocognitive disorders in psychiatry: a case example of diagnostic and treatment dilemmas.

Weinstein CS, Seidman LJ, Feldman JJ, Ratey JJ.

Psychiatry. 1991 Feb;54(1):65-75; discussion 76-7.

PMID:
2023975
18.

Cognition as an outcome measure in schizophrenia.

Kraus MS, Keefe RS.

Br J Psychiatry Suppl. 2007 Aug;50:s46-51. Review.

PMID:
18019044
19.

[Cognitive remediation and cognitive assistive technologies in schizophrenia].

Sablier J, Stip E, Franck N.

Encephale. 2009 Apr;35(2):160-7. doi: 10.1016/j.encep.2008.02.010. Epub 2008 Jun 2. French.

PMID:
19393385
20.

Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance.

Bell M, Bryson G, Greig T, Corcoran C, Wexler BE.

Arch Gen Psychiatry. 2001 Aug;58(8):763-8.

PMID:
11483142

Supplemental Content

Support Center